Indivior PLC announced on February 24, 2025, the FDA's approval of label changes for their product SUBLOCADE, indicating a positive regulatory development for the company.
AI Assistant
INDIVIOR PHARMACEUTICALS INC
2025
6 K
Find Answers
Ask about any part of the document to get insights, explanations, or key details.